A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women

Andrea A. Howard, Julia H. Arnsten, Yungtai Lo, David Vlahov, Josiah D. Rich, Paula Schuman, Valerie E. Stone, Dawn K. Smith, Ellie Schoenbaum

Research output: Contribution to journalArticle

217 Citations (Scopus)

Abstract

Objectives: To examine the relationship between antiretroviral adherence and viral load, and to determine the predictors of adherence over time in HIV-infected women. Design: Prospective observational study. Methods: One-hundred sixty-one HIV-infected women who were taking antiretroviral therapy for a median of 3.0 years were recruited from the HIV Epidemiology Research Study, a multicenter cohort study of HIV infection in women. Antiretroviral adherence (percent of doses taken as prescribed) was measured over a 6-month period using MEMS caps. At baseline and follow-up, CD4 lymphocyte count and viral load were measured, and a standardized interview was administered to elicit medication history and drug use behaviors. To examine changes in adherence over time, the mean adherence to all antiretroviral agents was calculated for each monitored month. Results: Adherence varied significantly over time (P < 0.001), ranging from a mean of 64% in month 1 to 45% in month 6. Nearly one-fourth of the participants had a 10% or greater decrease in adherence between consecutive months. Virologic failure occurred in 17% of women with adherence of ≥ 88%, 28% of those with 45-87% adherence, 43% of those with 13-44% adherence, and 71% of those with ≤ 12% adherence. In multivariate analysis, factors predicting lower adherence included active drug use, alcohol use, more frequent antiretroviral dosing, shorter duration of antiretroviral use, younger age, and lower initial CD4 lymphocyte count. Conclusions: Antiretroviral adherence is not stable over time. Interventions aimed at monitoring and improving long-term adherence in women are urgently needed.

Original languageEnglish (US)
Pages (from-to)2175-2182
Number of pages8
JournalAIDS
Volume16
Issue number16
DOIs
StatePublished - Nov 8 2002

Fingerprint

Viral Load
HIV
Prospective Studies
CD4 Lymphocyte Count
Micro-Electrical-Mechanical Systems
Anti-Retroviral Agents
Pharmaceutical Preparations
Multicenter Studies
HIV Infections
Observational Studies
Epidemiology
Cohort Studies
Multivariate Analysis
Alcohols
Interviews
Research
Therapeutics

Keywords

  • Adherence
  • Antiretroviral therapy
  • Compliance
  • Drug users
  • Electronic monitoring
  • Viral load
  • Women

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women. / Howard, Andrea A.; Arnsten, Julia H.; Lo, Yungtai; Vlahov, David; Rich, Josiah D.; Schuman, Paula; Stone, Valerie E.; Smith, Dawn K.; Schoenbaum, Ellie.

In: AIDS, Vol. 16, No. 16, 08.11.2002, p. 2175-2182.

Research output: Contribution to journalArticle

Howard, Andrea A. ; Arnsten, Julia H. ; Lo, Yungtai ; Vlahov, David ; Rich, Josiah D. ; Schuman, Paula ; Stone, Valerie E. ; Smith, Dawn K. ; Schoenbaum, Ellie. / A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women. In: AIDS. 2002 ; Vol. 16, No. 16. pp. 2175-2182.
@article{545aa903b2814d6288b1ffe9fd6540b0,
title = "A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women",
abstract = "Objectives: To examine the relationship between antiretroviral adherence and viral load, and to determine the predictors of adherence over time in HIV-infected women. Design: Prospective observational study. Methods: One-hundred sixty-one HIV-infected women who were taking antiretroviral therapy for a median of 3.0 years were recruited from the HIV Epidemiology Research Study, a multicenter cohort study of HIV infection in women. Antiretroviral adherence (percent of doses taken as prescribed) was measured over a 6-month period using MEMS caps. At baseline and follow-up, CD4 lymphocyte count and viral load were measured, and a standardized interview was administered to elicit medication history and drug use behaviors. To examine changes in adherence over time, the mean adherence to all antiretroviral agents was calculated for each monitored month. Results: Adherence varied significantly over time (P < 0.001), ranging from a mean of 64{\%} in month 1 to 45{\%} in month 6. Nearly one-fourth of the participants had a 10{\%} or greater decrease in adherence between consecutive months. Virologic failure occurred in 17{\%} of women with adherence of ≥ 88{\%}, 28{\%} of those with 45-87{\%} adherence, 43{\%} of those with 13-44{\%} adherence, and 71{\%} of those with ≤ 12{\%} adherence. In multivariate analysis, factors predicting lower adherence included active drug use, alcohol use, more frequent antiretroviral dosing, shorter duration of antiretroviral use, younger age, and lower initial CD4 lymphocyte count. Conclusions: Antiretroviral adherence is not stable over time. Interventions aimed at monitoring and improving long-term adherence in women are urgently needed.",
keywords = "Adherence, Antiretroviral therapy, Compliance, Drug users, Electronic monitoring, Viral load, Women",
author = "Howard, {Andrea A.} and Arnsten, {Julia H.} and Yungtai Lo and David Vlahov and Rich, {Josiah D.} and Paula Schuman and Stone, {Valerie E.} and Smith, {Dawn K.} and Ellie Schoenbaum",
year = "2002",
month = "11",
day = "8",
doi = "10.1097/00002030-200211080-00010",
language = "English (US)",
volume = "16",
pages = "2175--2182",
journal = "AIDS",
issn = "0269-9370",
publisher = "Lippincott Williams and Wilkins",
number = "16",

}

TY - JOUR

T1 - A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women

AU - Howard, Andrea A.

AU - Arnsten, Julia H.

AU - Lo, Yungtai

AU - Vlahov, David

AU - Rich, Josiah D.

AU - Schuman, Paula

AU - Stone, Valerie E.

AU - Smith, Dawn K.

AU - Schoenbaum, Ellie

PY - 2002/11/8

Y1 - 2002/11/8

N2 - Objectives: To examine the relationship between antiretroviral adherence and viral load, and to determine the predictors of adherence over time in HIV-infected women. Design: Prospective observational study. Methods: One-hundred sixty-one HIV-infected women who were taking antiretroviral therapy for a median of 3.0 years were recruited from the HIV Epidemiology Research Study, a multicenter cohort study of HIV infection in women. Antiretroviral adherence (percent of doses taken as prescribed) was measured over a 6-month period using MEMS caps. At baseline and follow-up, CD4 lymphocyte count and viral load were measured, and a standardized interview was administered to elicit medication history and drug use behaviors. To examine changes in adherence over time, the mean adherence to all antiretroviral agents was calculated for each monitored month. Results: Adherence varied significantly over time (P < 0.001), ranging from a mean of 64% in month 1 to 45% in month 6. Nearly one-fourth of the participants had a 10% or greater decrease in adherence between consecutive months. Virologic failure occurred in 17% of women with adherence of ≥ 88%, 28% of those with 45-87% adherence, 43% of those with 13-44% adherence, and 71% of those with ≤ 12% adherence. In multivariate analysis, factors predicting lower adherence included active drug use, alcohol use, more frequent antiretroviral dosing, shorter duration of antiretroviral use, younger age, and lower initial CD4 lymphocyte count. Conclusions: Antiretroviral adherence is not stable over time. Interventions aimed at monitoring and improving long-term adherence in women are urgently needed.

AB - Objectives: To examine the relationship between antiretroviral adherence and viral load, and to determine the predictors of adherence over time in HIV-infected women. Design: Prospective observational study. Methods: One-hundred sixty-one HIV-infected women who were taking antiretroviral therapy for a median of 3.0 years were recruited from the HIV Epidemiology Research Study, a multicenter cohort study of HIV infection in women. Antiretroviral adherence (percent of doses taken as prescribed) was measured over a 6-month period using MEMS caps. At baseline and follow-up, CD4 lymphocyte count and viral load were measured, and a standardized interview was administered to elicit medication history and drug use behaviors. To examine changes in adherence over time, the mean adherence to all antiretroviral agents was calculated for each monitored month. Results: Adherence varied significantly over time (P < 0.001), ranging from a mean of 64% in month 1 to 45% in month 6. Nearly one-fourth of the participants had a 10% or greater decrease in adherence between consecutive months. Virologic failure occurred in 17% of women with adherence of ≥ 88%, 28% of those with 45-87% adherence, 43% of those with 13-44% adherence, and 71% of those with ≤ 12% adherence. In multivariate analysis, factors predicting lower adherence included active drug use, alcohol use, more frequent antiretroviral dosing, shorter duration of antiretroviral use, younger age, and lower initial CD4 lymphocyte count. Conclusions: Antiretroviral adherence is not stable over time. Interventions aimed at monitoring and improving long-term adherence in women are urgently needed.

KW - Adherence

KW - Antiretroviral therapy

KW - Compliance

KW - Drug users

KW - Electronic monitoring

KW - Viral load

KW - Women

UR - http://www.scopus.com/inward/record.url?scp=0037045043&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037045043&partnerID=8YFLogxK

U2 - 10.1097/00002030-200211080-00010

DO - 10.1097/00002030-200211080-00010

M3 - Article

C2 - 12409739

AN - SCOPUS:0037045043

VL - 16

SP - 2175

EP - 2182

JO - AIDS

JF - AIDS

SN - 0269-9370

IS - 16

ER -